Cardiology

Lipoprotein(a) is a molecule made from joining a protein the body makes (called apolipoprotein(a)) and LDL, which is a form of cholesterol. The importance of the Measurement and lowering of Lipoprotein(a) is an area of active research. It is one of a group of molecules called 'lipoproteins', so called because they have this common form of construction - a protein attached to a cholesterol molecule. Having elevated levels of lipoprotein(a) in their blood has been strongly implicated in research as a risk factor for cardiovascular disease - such as coronary heart disease (CHD) or stroke.

Man health Australian men's health issue, men's health care, male mental health current health issue of men's health issue of men in Australia

A recent review showed that fibrates, drugs used in cholesterol lowering therapy, are less effective for treating hypercholesterolaemia than statins.

Maintaining appropriate levels of physical activity with cardiovascular disease is now thought to be very important. We now know that people who take up regular…

Dual inhibition is a cholesterol lowering therapy in which two types of medications (a statin and ezetimibe) are combined to treat hypercholesterolaemia.

Statins are a class of lipid-lowering drugs used to treat hypercholesterolaemia, in which there are high levels of LDL (bad) cholesterol in the blood.

Low density lipoprotein cholesterol lowering therapies are used to treat high cholesterol levels and reduce the progression of heart disease.

Coronary heart disease is caused by narrowing of the blood vessels of the heart. It results in heart failure, heart attack and/or unstable angina.

Cachexia refers to rapid wasting of muscles and tissues which cannot be explained by under-nutrition alone. It is a common complication of cancer and AIDS.